|
测量指标：
Outcomes：
|
|
指标中文名：
|
PG-SGA
|
指标类型：
|
主要指标
|
|
Outcome：
|
PG-SGA
|
Type：
|
Primary indicator
|
|
测量时间点：
|
|
测量方法：
|
|
|
Measure time point of outcome：
|
|
Measure method：
|
|
|
指标中文名：
|
安全性
|
指标类型：
|
副作用指标
|
|
Outcome：
|
safety
|
Type：
|
Adverse events
|
|
测量时间点：
|
|
测量方法：
|
试验组患者或家属通过微信小程序“班小二”或纸质版“摄入食疗相关不适症状记录表”记录摄入食疗相关不适症状，如腹泻。计算摄食食疗相关不适症状（如腹泻）的发生次数评价食疗安全性。安全性在2个化疗周期结束后（42天，即6周）收集
|
|
Measure time point of outcome：
|
|
Measure method：
|
Patients or their family members in the test group recorded the symptoms of discomfort associated with ingestion of therapeutic feeding, such as diarrhoea, through the WeChat app ‘Banxiao Er’ or the paper version of the ‘Record of Symptoms Associated with Ingested Therapeutic Feeding’ form. The safety of therapeutic feeding will be evaluated by counting the number of episodes of therapeutic feeding-related symptoms (e.g., diarrhoea). Safety was c
|
|
指标中文名：
|
食疗知信行水平
|
指标类型：
|
次要指标
|
|
Outcome：
|
Food Therapy Knowledge, Trust and Practice Level
|
Type：
|
Secondary indicator
|
|
测量时间点：
|
|
测量方法：
|
采用李芳编制的《居民药膳食疗行为影响因素问卷》进行调查。包含药膳食疗知识、信念、主观规范、知觉行为控制、行为五个维度，共 45 个条目。
|
|
Measure time point of outcome：
|
|
Measure method：
|
The Questionnaire on Influencing Factors of Residents' Medicinal Food Therapy Behaviour prepared by Li Fang was used for the survey. It contains five dimensions of medicinal dietary food therapy knowledge, beliefs, subjective norms, perceived behavioural control, and behaviours, with a total of 45 entries.
|
|
指标中文名：
|
中医证候
|
指标类型：
|
次要指标
|
|
Outcome：
|
Chinese medicine evidence and symptoms
|
Type：
|
Secondary indicator
|
|
测量时间点：
|
|
测量方法：
|
采用中医症状及体征评分量表进行评估，包括失眠多梦、消瘦、腹泻、神疲乏力、气短、心悸、少气懒言、面色萎黄或苍白、头晕目眩9个条目，根据症状轻重分为无、轻、中、重，分别为0、1、2、3分。
|
|
Measure time point of outcome：
|
|
Measure method：
|
The assessment was performed using the Chinese Medicine Symptoms and Signs Rating Scale, which included 9 entries of insomnia and dreaminess, emaciation, diarrhoea, fatigue, shortness of breath, palpitation, less breath and lazy speech, yellowish or pale complexion, and dizziness, which were classified as none, light, moderate, and severe according to the severity of the symptoms, with scores of 0, 1, 2, and 3, respectively. Translated with www.
|
|
指标中文名：
|
生活质量
|
指标类型：
|
次要指标
|
|
Outcome：
|
quality of life
|
Type：
|
Secondary indicator
|
|
测量时间点：
|
|
测量方法：
|
采用欧洲癌症研究与治疗组织的生命质量核心量表（EORTC QLQ-C30量表），欧洲癌症研究与治疗组织于1986年开始研制面向癌症病人的核心量表（普适性量表），在此基础上增加不同的特异性条目（模块），即构成不同病种的特异量表。
|
|
Measure time point of outcome：
|
|
Measure method：
|
The European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Core Scale (EORTC QLQ-C30 scale) was used. The EORTC started to develop a core scale (universal scale) for cancer patients in 1986, to which different specific entries (modules) were added, i.e., constituting disease-specific scales.
|
|
指标中文名：
|
肌肉质量
|
指标类型：
|
主要指标
|
|
Outcome：
|
muscle mass
|
Type：
|
Primary indicator
|
|
测量时间点：
|
|
测量方法：
|
通过握力/体重比值（hand grip strength/weight ratio, HGS/W）评价肌肉质量。使用香山CAMRY EH101电子握力计（弹簧式）测量非惯用臂的HGS，测量3次得到平均值，将HGS除以W得到HGS/W。测量方法：患者身体站立挺直，双腿自然分开，双臂自然下垂，肘部向外伸展15-45°。患者以直角（90°）握住电子握力计并使出自身最大力量，重复测量三次，每次间隔30s。
|
|
Measure time point of outcome：
|
|
Measure method：
|
Muscle mass was evaluated by grip strength/weight ratio (HGS/W). The HGS of the non-dominant arm was measured with a CAMRY EH101 electronic grip strength meter (spring-loaded), and the average value was obtained by taking three measurements and dividing the HGS by W to obtain the HGS/W. Measurement method: The patient's body stood up straight, with legs naturally apart, arms naturally hanging down, and elbows extended outward by 15-45°. The patie
|
|
指标中文名：
|
NRS 2002
|
指标类型：
|
主要指标
|
|
Outcome：
|
NRS 2002
|
Type：
|
Primary indicator
|
|
测量时间点：
|
|
测量方法：
|
|
|
Measure time point of outcome：
|
|
Measure method：
|
|
|
